Operating Expenses Summary of BIOTON S.A.

BIOTON S.A.'s latest annual operating expenses in 2023 was 57.55 Million PLN , up 8.92% from previous year.
BIOTON S.A.'s latest quarterly operating expenses in 2024 Q2 was 19.84 Million PLN , up 15.06% from previous quarter.
BIOTON S.A. reported a annual operating expenses of 69.74 Million PLN in annual operating expenses 2022, up 7.02% from previous year.
BIOTON S.A. reported a annual operating expenses of 65.16 Million PLN in annual operating expenses 2021, up 26.41% from previous year.
BIOTON S.A. reported a quarterly operating expenses of 16.41 Million PLN for 2024 Q1, down -40.5% from previous quarter.
BIOTON S.A. reported a quarterly operating expenses of 16.49 Million PLN for 2023 Q3, down -7.46% from previous quarter.

Annual Operating Expenses Chart of BIOTON S.A. (2023 - 2005)

Historical Annual Operating Expenses of BIOTON S.A. (2023 - 2005)

Year	Operating Expenses	Operating Expenses Growth
2023	57.55 Million PLN	8.92%
2022	69.74 Million PLN	7.02%
2021	65.16 Million PLN	26.41%
2020	51.55 Million PLN	-56.35%
2019	118.1 Million PLN	-28.96%
2018	166.24 Million PLN	-0.56%
2017	167.17 Million PLN	6.39%
2016	157.13 Million PLN	6.63%
2015	147.37 Million PLN	5.17%
2014	140.12 Million PLN	0.06%
2013	140.04 Million PLN	-6.75%
2012	150.18 Million PLN	-2.25%
2011	153.64 Million PLN	13.64%
2010	135.2 Million PLN	-79.69%
2009	665.84 Million PLN	231.87%
2008	200.63 Million PLN	319.92%
2007	47.77 Million PLN	-18.99%
2006	58.98 Million PLN	49.42%
2005	39.47 Million PLN	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	19.84 Million PLN	15.06%
2024 Q1	16.41 Million PLN	-40.5%
2023 Q3	16.49 Million PLN	-7.46%
2023 Q2	17.82 Million PLN	4.45%
2023 Q1	17.06 Million PLN	-14.57%
2023 FY	75.96 Million PLN	8.92%
2023 Q4	27.59 Million PLN	67.3%
2022 Q2	17.67 Million PLN	17.83%
2022 Q3	17.65 Million PLN	-0.11%
2022 Q4	19.97 Million PLN	13.09%
2022 FY	69.74 Million PLN	7.02%
2022 Q1	15 Million PLN	-25.23%
2021 FY	65.16 Million PLN	26.41%
2021 Q1	16.23 Million PLN	52.57%
2021 Q4	20.06 Million PLN	37.41%
2021 Q2	17.37 Million PLN	6.98%
2021 Q3	14.6 Million PLN	-15.93%
2020 Q4	10.64 Million PLN	-40.31%
2020 FY	51.55 Million PLN	-56.35%
2020 Q1	897 Thousand PLN	101.14%
2020 Q2	22.48 Million PLN	2406.58%
2020 Q3	17.83 Million PLN	-20.7%
2019 Q1	27.72 Million PLN	-54.38%
2019 Q2	145.11 Million PLN	423.39%
2019 Q3	24.08 Million PLN	-83.4%
2019 Q4	-78.71 Million PLN	-426.8%
2019 FY	118.1 Million PLN	-28.96%
2018 Q3	24.94 Million PLN	-40.97%
2018 Q1	38.26 Million PLN	-23.57%
2018 FY	166.24 Million PLN	-0.56%
2018 Q2	42.26 Million PLN	10.47%
2018 Q4	60.77 Million PLN	143.59%
2017 Q4	50.06 Million PLN	16.58%
2017 FY	167.17 Million PLN	6.39%
2017 Q3	42.94 Million PLN	9.83%
2017 Q2	39.09 Million PLN	11.44%
2017 Q1	35.08 Million PLN	-26.1%
2016 Q4	47.47 Million PLN	40.3%
2016 FY	157.13 Million PLN	6.63%
2016 Q1	35.29 Million PLN	-20.96%
2016 Q2	40 Million PLN	13.35%
2016 Q3	33.83 Million PLN	-15.42%
2015 FY	147.37 Million PLN	5.17%
2015 Q4	44.65 Million PLN	31.03%
2015 Q3	34.07 Million PLN	-8.4%
2015 Q2	37.2 Million PLN	17.27%
2015 Q1	31.72 Million PLN	-29.75%
2014 FY	140.12 Million PLN	0.06%
2014 Q3	33.9 Million PLN	-5.86%
2014 Q2	36.01 Million PLN	20.38%
2014 Q4	45.16 Million PLN	33.2%
2014 Q1	29.91 Million PLN	-31.65%
2013 FY	140.04 Million PLN	-6.75%
2013 Q4	43.77 Million PLN	39.22%
2013 Q2	36.01 Million PLN	15.99%
2013 Q1	31.04 Million PLN	-23.96%
2013 Q3	31.44 Million PLN	-12.69%
2012 Q2	41.23 Million PLN	15.41%
2012 Q1	35.72 Million PLN	-10.66%
2012 FY	150.18 Million PLN	-2.25%
2012 Q3	32.39 Million PLN	-21.43%
2012 Q4	40.83 Million PLN	26.04%
2011 Q3	35.62 Million PLN	-16.1%
2011 FY	153.64 Million PLN	13.64%
2011 Q1	35.58 Million PLN	-9.9%
2011 Q2	42.45 Million PLN	19.33%
2011 Q4	39.98 Million PLN	12.26%
2010 Q1	29.55 Million PLN	-94.64%
2010 Q3	31.15 Million PLN	-11.0%
2010 FY	135.2 Million PLN	-79.69%
2010 Q4	39.48 Million PLN	26.75%
2010 Q2	35 Million PLN	18.45%
2009 Q3	26.37 Million PLN	-56.23%
2009 Q4	551.46 Million PLN	1991.1%
2009 Q2	60.25 Million PLN	117.08%
2009 Q1	27.75 Million PLN	0.0%
2009 FY	665.84 Million PLN	231.87%
2008 FY	200.63 Million PLN	319.92%
2007 FY	47.77 Million PLN	-18.99%
2006 FY	58.98 Million PLN	49.42%
2005 FY	39.47 Million PLN	0.0%

Peer Operating Expenses Comparison of BIOTON S.A.

Name	Operating Expenses	Operating Expenses Difference
Bioceltix S.A.	15.38 Million PLN	-274.123%
Captor Therapeutics Spolka Akcyjna	79.91 Million PLN	27.978%
Mabion S.A.	59.52 Million PLN	3.3%
Molecure S.A.	31.73 Million PLN	-81.397%
NanoGroup S.A.	7.82 Million PLN	-635.41%
Pharmena S.A.	-32.76 Million PLN	275.669%
Poltreg S.A.	15.47 Million PLN	-271.942%
Pure Biologics Spólka Akcyjna	29.14 Million PLN	-97.495%
Ryvu Therapeutics S.A.	4.73 Million PLN	-1114.816%
Synthaverse S.A.	26.35 Million PLN	-118.403%
Urteste S.A.	5.96 Million PLN	-864.444%

Global Stocks Search

BIOTON S.A. (BIO.WA)

Operating Expenses Summary of BIOTON S.A.

Annual Operating Expenses Chart of BIOTON S.A. (2023 - 2005)

Historical Annual Operating Expenses of BIOTON S.A. (2023 - 2005)

Peer Operating Expenses Comparison of BIOTON S.A.